SCHEMBL7980800

SCHEMBL7980800

C[C@H]1CC(N)(Nc2cccc(F)c2)CCN1C(=O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
HTR2C P28335 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM1A O60341 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
KCNJ6 P48051 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1170577 0.88 PDK1 (0.41) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL1170399 0.88 PDK1 (0.41) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL2434192 0.87 PDK1 (0.42) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL12328094 0.86 PDK1 (0.41) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL10262476 0.86 JAK2 (0.42) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL12328090 0.86 PDK1 (0.41) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL1170330 0.86 JAK2 (0.42) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL1170610 0.86 JAK2 (0.42) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL755045 0.86 JAK2 (0.42) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL21241492 0.77 HTR2C (0.52) PDK1PDK2PDK3PDK4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO disclosed